NHS warning over the common medications you should never mix with paracetamol
Paracetamol and ibuprofen are two of the most commonly used and widely available painkillers in the UK, but there are certain medications that should not be taken alongside them
The NHS has issued a warning to those on certain medications about the potential hazards of combining them with commonly-used painkillers. The health service advises consulting with your doctor or pharmacist before taking paracetamol or ibuprofen if you're affected.
Many rely on over-the-counter remedies like paracetamol for common complaints including headaches, backaches, and the symptoms of colds. Ibuprofen is another accessible pain reliever in the UK, used against various discomforts such as back and period pains, toothaches, and symptoms related to colds, flu, or COVID-19.
While these medications are typically safe when used according to instructions, the NHS lists medicines that should not be mixed with either paracetamol and ibuprofen.
Read on to see which tablets you should avoid mixing with the popular painkillers.
Paracetamol
With regard to paracetamol, the NHS suggests speaking with your GP prior to use if you are on certain drugs. Specifically, they warn against the use of the painkiller along with warfarin, a medicine used to prevent blood clots, reports the Express.
They said: "Paracetamol can increase the risk of bleeding if you take it [warfarin] regularly."
However, a lower dose of paracetamol can be safe alongside warfarin, with the health service clarifying: "It's safe to take paracetamol while you're on warfarin. But take the lowest dose that controls your pain.
"Taking more than four 500mg tablets over 24 hours for longer than a few days may make your blood clot more slowly. This puts you at risk of bleeding."
It can also be potentially hazardous to take the painkiller alongside other medications that contain paracetamol such as co-codamol or certain cold and flu tablets, due to the risk of overdose. However, ibuprofen, aspirin and codeine are other painkillers that do not contain paracetamol and are safe to take with paracetamol.
The NHS advises that you should consult your doctor before taking paracetamol if you are on medicine to treat epilepsy or tuberculosis (TB) as this can also pose an added risk.
Ibuprofen
These include aspirin, diclofenac, celecoxib and naproxen, and when taken together could heighten the risk of side effects such as stomach bleeding or kidney problems.
"NSAIDs are also used in medicines you can purchase from pharmacies, such as cough and cold remedies," states the NHS. "Before taking any other medicines, check the label to see if they contain aspirin, ibuprofen or other NSAIDs."
For your safety, you should also inform your doctor if you're taking any of the following medicines before you start taking any type of ibuprofen:
Medicines that help to prevent blood clots, such as warfarin
Medicines for high blood pressure
Steroid medicines such as betamethasone, dexamethasone, hydrocortisone or prednisolone
Antibiotics such as ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin or ofloxacin
Antidepressants such as citalopram, fluoxetine, fluvoxamine, venlafaxine, paroxetine or sertraline
Diabetes medicines such as gliclazide, glimepiride, glipizide or tolbutamide.
You should also avoid taking ibuprofen with ginkgo biloba supplements as it can 'increase the chance of bleeding'. The NHS added that you should see a doctor as soon as possible or call 111 if you have been taking ibuprofen and you experience:
Black poo or blood in your vomit – these can be signs of bleeding in your stomach.
Swollen ankles, blood in your pee or not peeing at all – these can be signs of a kidney problem.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
44 minutes ago
- The Independent
Denying joint operations to obese patients is counterproductive
We fear that there are going to be many more stories such as this about the National Health Service before the wounds of a decade of underfunding followed by the coronavirus pandemic start to heal. Rebecca Thomas, our award-winning health correspondent, reports today that obese patients are being denied life-changing hip and knee replacements, and being left in pain as the NHS attempts to cut costs. One-third of NHS areas in England and some health boards in Wales are refusing joint replacement operations to patients who exceed a given body mass index. This is contrary to guidance from the National Institute for Health and Care Excellence (NICE), the body responsible for deciding whether treatments are value for money. Of course, as long as healthcare is rationed, difficult choices will have to be made. And the blunt truth is that all expensive treatments on the NHS are rationed, as they have to be in a system of limited resources. Instead of being rationed by ability to pay, the usual mechanism for rationing in the NHS is queueing. At the same time, however, treatments are also rationed by need, and it is the role of NICE to help to decide which groups of patients should be prioritised over others. We can understand why some parts of the NHS might de-prioritise obese patients for hip and knee replacements. It might be argued that obesity is the cause of joint problems and that therefore treatment should focus on weight loss, or else the problems are likely to recur with the artificial joints. But the NICE guidelines recognise that causation may not be all one way and that for many patients joint problems contribute to obesity rather than the other way round. In which case, joint replacement is the key to reducing weight, allowing patients to exercise more. This is a field of healthcare undergoing rapid transition, as the availability of weight-loss drugs such as Ozempic has changed the options available to patients, offering hope of treatment without surgery. But it remains important that overweight patients do not face a sweeping ban on joint replacement operations on the basis of arbitrary body mass index counts – especially as these BMI limits vary from area to area across the NHS. It is devoutly to be wished that this new government is beginning to turn the NHS round. Rachel Reeves, the chancellor, will confirm at the spending review on 11 June that the health service will be allocated substantial increases in resources over the next four years. Wes Streeting, the health secretary, has already taken the risk of overclaiming the improvement that has been made in just 11 months since the election. He claimed that waiting lists had fallen for six months in a row, only for the latest figure, for month seven, to show a small increase. His claim of having met his target for the number of new appointments 'seven months early' was undermined by figures obtained by Full Fact, the fact-checking charity, suggesting the rate of increase has in fact been slower than last year. We hope that resident doctors will vote against strike action, in order to allow these early, if overstated, signs of improvement to turn into real progress. In the meantime, difficult choices about whom to treat, and whom to treat first, will continue to beset the health service. In making those decisions, doctors must avoid unfair and discriminatory blanket bans based on arbitrary weight limits.
The Independent
2 hours ago
- The Independent
Obese patients denied knee and hip replacements to slash NHS costs
Obese patients are being denied life-changing hip and knee replacements and left in pain in a bid to slash spiralling NHS costs, The Independent can reveal. One third of NHS areas in England and multiple health boards in Wales are blocking patient access based on their body mass index (BMI). The move, deemed 'unfair' and 'discriminatory', goes against guidance from the National Institute for Care Excellence (Nice), which states BMI shouldn't be used to restrict patients' access to joint replacement surgery. Patients are instead being told they must lose weight before they are eligible but waiting lists for NHS weight loss programs have ballooned, with some people waiting up to three years to be seen while other services have shut, unable to cope with demand. The Royal College of Surgeons criticised the policy, saying that denying patients care could cost them their mobility and cause their health to deteriorate, while Tory peer and former health minister James Bethell called on the government to do more to tackle the obesity crisis and end the 'misery for millions'. More than 64 per cent of adults in England were overweight or living with obesity in 2022-23, up from 63 per cent the year before, the most recent data from the Office for National Statistics shows. The news comes as 7.4 million people were waiting for NHS treatments in March, while health service leaders have warned they are being forced to cut services to meet tough savings demands from the government. The shocking revelation of surgery refusals was uncovered in an audit of referral criteria used by NHS bodies in England by the National Institute for Health and Care Research (NIHR). It found 15 of 42 areas are restricting access to surgery by BMI, while The Independent discovered at least two health boards were doing the same in Wales. Thresholds varied by area, with some limiting access to those with a BMI of less than 35 (patients who are obese) or 40 (severely obese). Dr Joanna McLaughlin, lead researcher and NIHR clinical lecturer at the University of Bristol, told The Independent that through her research, policymakers, commissioners and surgeons 'acknowledged that NHS financial pressures were a main driver for BMI threshold policy use, and that they didn't have confidence that the policies were based in evidence of health benefits'. The research also found that NHS weight management support services were 'inadequate' and could not ensure that those excluded from surgery could be supported to lose enough weight. Some patients had resorted to paying privately for surgery. Dr McLaughlin said: 'The variety in the BMI limits and in the requirements to prove patients have made attempts at weight loss chosen by different ICBs [integrated care boards] highlights the postcode lottery and inequalities created by these policies.' Several ICBs identified by the study told The Independent that some patients with a high BMI could still access care if they passed an assessment, while others said they would need to prove they were 'fit for surgery'. But medics told The Independent that BMI should not be used as a sole restrictive measure. Tim Mitchell, president of the Royal College of Surgeons of England, said losing weight before surgery could reduce the risk of complications, and patients should be supported in this. However, he said that 'BMI alone should not be a barrier', adding: 'We must not penalise those who are less fit but still eligible for surgery, as this approach is unfair and ignores clinical guidance.' Mark Bowditch, president of the British Orthopaedic Association, said: 'Losing weight before surgery can be very difficult for people with limited mobility issues. 'Furthermore, obesity is more likely in people from certain socioeconomically deprived areas or ethnic groups, so care must be taken to avoid unintentionally disadvantaging certain patient groups.' Deborah Alsina, chief executive of charity Versus Arthritis, said: 'We hear heartbreaking stories from people desperate for the pain to stop, and accounts from people who face barriers to access even when they are referred for the surgery they urgently need. 'We frequently hear of people denied a referral, or being taken off the waiting list because of their weight, with body mass index being cited as a rationale. We must make sure this discriminatory practice doesn't become standard.' Lord Bethell said the row over BMI thresholds for operations showed the NHS 'needs to make a choice' over preventing disease with weight-loss jabs, which cost £100 a month, or to treat obesity-related diseases, such as those that lead to hip operations, which can cost £10,000. He said the government has a choice to either crack down on 'Junk Food Britain' with a tough food strategy or to give the NHS a lot more money to pay for the consequences of a sick population. He added: 'It's one or the other. Ducking this choice will cause misery for millions, the bankruptcy of our nation and the end of the Starmer administration.' A Department of Health and Social Care spokesperson said it expected ICBs to comply with Nice guidance. They added that the department's 'Plan for Change' for the NHS includes rolling out weight loss drugs to 'those who need it most'.
Daily Mail
2 hours ago
- Daily Mail
Are YOU eligible for weight-loss jabs on the NHS? ETHAN ENNALS reveals the official new documents that determine if you can get the drugs for FREE from your GP
It is the biggest shake-up of obesity treatment in NHS history, it has been claimed. From later this month, GPs will be able to prescribe weight-loss jabs to thousands. These once-a-week injections – Wegovy and Mounjaro – can help patients shed up to a fifth of their body weight in only a year.
